Creative Planning’s Oruka Therapeutics ORKA Stock Holding History

Creative Planning’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Buy	15,738 +3,002	+24%	+$200K	﹤0.01%	2322
2026 Q1	$625K	Buy	12,736 +5,040	+65%	+$175K	﹤0.01%	2851
2025 Q4	$233K	Buy	+7,696	New	+$214K	﹤0.01%	3432
2017 Q3	–	Hold	0	–	–	–	3788
2017 Q2	–	Hold	0	–	–	–	4867
2017 Q1	–	Hold	0	–	–	–	4943
2016 Q4	–	Sell	-1	Closed	-$532	–	4879
2016 Q3	$0	Hold	1	–	–	﹤0.01%	4761
2016 Q2	$0	Buy	+1	New	+$740	﹤0.01%	4554

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Creative Planning's ORKA Position: Q2 2026 in Review

Creative Planning increased its Oruka Therapeutics (ORKA) stake by 24% in Q2 2026, buying an estimated $200K and bringing the position to 15,738 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

Creative Planning first reported a position in ORKA in Q2 2016 and has held it in 5 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Creative Planning held 15,738 shares of Oruka Therapeutics worth $1.5M as of Q2 2026.
Creative Planning bought 3,002 Oruka Therapeutics shares in Q2 2026, an estimated $200K.
Oruka Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2322 holding.
Creative Planning first reported a position in Oruka Therapeutics in Q2 2016 and has held it in 5 quarters since.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.